Coeliac disease is an autoimmune disorder occurring in genetically susceptible individuals when they consume food containing gluten.

The diagnosis of Coeliac disease relies on the accurate measurement of biomarkers, such as specific antibodies (called anti-tTG antibodies) found in blood.

Despite available medical laboratory tests, diagnosing and treating this disease remains challenging, due to a lack of harmonisation in test results, both for diagnosis and treatment evaluation.

The new certified reference material will serve as a common reference point across different testing methods, laboratories and countries, which is essential for ensuring accuracy and consistency in coeliac disease diagnosis.

Read online article